![Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease | Journal of Pharmacology and Experimental Therapeutics Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/380/3/210/F1.large.jpg)
Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease | Journal of Pharmacology and Experimental Therapeutics
![Oceanography and Marine Biology: An annual review. Volume 42: Gibson, R. N., Atkinson, R. J. A., Gordon, J. D. M., Gibson, R. N., Atkinson, R. J. A., Gordon, J. D. M., Wotton, Oceanography and Marine Biology: An annual review. Volume 42: Gibson, R. N., Atkinson, R. J. A., Gordon, J. D. M., Gibson, R. N., Atkinson, R. J. A., Gordon, J. D. M., Wotton,](https://m.media-amazon.com/images/I/41se8cY7X9L._AC_UF1000,1000_QL80_.jpg)
Oceanography and Marine Biology: An annual review. Volume 42: Gibson, R. N., Atkinson, R. J. A., Gordon, J. D. M., Gibson, R. N., Atkinson, R. J. A., Gordon, J. D. M., Wotton,
![Frontiers | Clinical Characteristics and Long-Term Outcomes of Patients With Differing Haemoglobin Levels Undergoing Semi-Urgent and Elective Percutaneous Coronary Intervention in an Asian Population Frontiers | Clinical Characteristics and Long-Term Outcomes of Patients With Differing Haemoglobin Levels Undergoing Semi-Urgent and Elective Percutaneous Coronary Intervention in an Asian Population](https://www.frontiersin.org/files/Articles/687555/fcvm-09-687555-HTML/image_m/fcvm-09-687555-g001.jpg)
Frontiers | Clinical Characteristics and Long-Term Outcomes of Patients With Differing Haemoglobin Levels Undergoing Semi-Urgent and Elective Percutaneous Coronary Intervention in an Asian Population
![The Shr receptor from Streptococcus pyogenes uses a cap and release mechanism to acquire heme–iron from human hemoglobin | PNAS The Shr receptor from Streptococcus pyogenes uses a cap and release mechanism to acquire heme–iron from human hemoglobin | PNAS](https://www.pnas.org/cms/asset/b8988970-06df-4670-9923-ff0f630ea45b/keyimage.jpg)
The Shr receptor from Streptococcus pyogenes uses a cap and release mechanism to acquire heme–iron from human hemoglobin | PNAS
![Spinal cord repair is modulated by the neurogenic factor Hb-egf under direction of a regeneration-associated enhancer | Nature Communications Spinal cord repair is modulated by the neurogenic factor Hb-egf under direction of a regeneration-associated enhancer | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-023-40486-5/MediaObjects/41467_2023_40486_Fig1_HTML.png)